Forxiga approved in EU for chronic heart failure
Forxiga (dapagliflozin) has been approved in the EU for chronic heart failure across the full spectrum of left ventricular ejection fraction.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
